Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 11;42(3):973–990. doi: 10.3892/or.2019.7230

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Wang et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 5. — miR-543 inhibits the cell apoptosis of OSCC cell lines. FCM was used to detect the cell apoptosis. (A) FCM revealed that the apoptotic rates of SCC9, SCC25 and CAL27 cells were decreased by 5.07, 9.37 and 10.97% on average following transfection with the miR-543 mimic, respectively. FCM, flow cytometry; miR, microRNA; OSCC, oral squamous cell carcinoma; NC, negative control. (B) The apoptotic rates of SCC9, SCC25 and CAL27 cells were increased by 7.83, 8.33 and 7.8% on average following transfection with the miR-543 inhibitor, respectively. *P<0.05, **P<0.01, ***P<0.001. FCM, flow cytometry; miR, microRNA; OSCC, oral squamous cell carcinoma; NC, negative control.

Figure 5. — miR-543 inhibits the cell apoptosis of OSCC cell lines. FCM was used to detect the cell apoptosis. (A) FCM revealed that the apoptotic rates of SCC9, SCC25 and CAL27 cells were decreased by 5.07, 9.37 and 10.97% on average following transfection with the miR-543 mimic, respectively. FCM, flow cytometry; miR, microRNA; OSCC, oral squamous cell carcinoma; NC, negative control. (B) The apoptotic rates of SCC9, SCC25 and CAL27 cells were increased by 7.83, 8.33 and 7.8% on average following transfection with the miR-543 inhibitor, respectively. *P<0.05, **P<0.01, ***P<0.001. FCM, flow cytometry; miR, microRNA; OSCC, oral squamous cell carcinoma; NC, negative control.